$NOVO B (+9,06%)

$NVO (+8,06%)

The Novo share has lost around 72% since its high in mid-2024. Numerous dips have been bought in these approximately 1.5 years. Perhaps a few were able to take short-term profits, many others probably closed their positions at a loss, but the vast majority are probably still in the red and are simply waiting to break even (as I did with Metaplanet 🤪).

Isn't this a catastrophe? Doesn't this constellation sabotage any upward breakout because selling pressure is created immediately?

Perhaps the turnaround will succeed anyway, but perhaps it will take much longer than one might currently assume. Have you ever experienced a similar decline, accompanied by so much euphoric buy-the-dip followed by paper hands? How did it end?

I certainly don't expect a black swan like "Warren Buffett goes big". On the contrary, I fear that Eli Lilly will also follow suit with a weight loss pill.

The analysts are still quite pessimistic with a consensus hold rating and an average price target of $53.33, which is the equivalent of around DKK 338 and therefore a price potential of "only" around 4.5%.

While sales are declining, debt is increasing 👇

But where is the money going, the capex investments are significantly lower than the debt?

Share buybacks are not relevant either...

In view of all this, perhaps I should regard my long-term position as a successful swing trade and realize it 😵‍💫

The following small positions were reversed:

$VOW (-0,52%) (3)

$DEZ (-2,37%) (25)

Newly included:

$FTNT (-1,19%) (10)

Increased:

$NOVO B (+9,06%) (9)

I wanted to tidy up my portfolio a bit, as these small positions were just bobbing around and I hadn't really thought through both investments.

I also wanted to take up a cybersecurity position.

Thank you for the early information back then regarding the GLP 1 pill from Novo.

$NOVO B (+9,06%)

$NVO (+8,06%)

Hi Community, can it be advantageous to sell individual stocks with which you are heavily in the red (€ 800 minus), such as Novo Nordisk in my case now $NOVO B (+9,06%) in order to receive a tax correction, as I have sold significantly more shares at a profit and have therefore paid a lot of tax? I still believe in the company and would buy it again immediately. Is there a catch?

Hello everyone,

I want to add a Japanese satellite to my portfolio. In future, my setup will consist of 75% core ($FWRG (+0,37%)
$EQQQ (+0,16%)
$EWG2 (+0,61%)
$BTC (-1,48%)) and 25 % satellites (e.g. $NOVO B (+9,06%)
$ASML (+0,31%)
$1810 (-2,17%)
$LMND (-3,58%)
$IREN (+0,33%)
$HIMS (-0,17%)
$601318).

After I have $6920 Lasertec and $3350 (+2,27%) Metaplanet, the decision was made in favor of $6861 (+2,41%) Keyence.

For me, it's the ideal quality anchor to balance out the volatility of my crypto bets (Irish/BTC) without sacrificing massive growth potential.

How do you currently see Japan? Are you more interested in chip stocks like Lasertec or quality machines like Keyence? 👇

Hi everyone,

I would really appreciate your opinion on my portfolio.

Briefly about me:

I am 38 years old and unfortunately only started my Trade Republic portfolio about 2 years ago. I have been investing regularly since then. I can currently invest around €350 per month - I work in a gym 🥲, and unfortunately you don't earn very well there, you could almost call it a pittance.

In addition, I have my Bitcoin and Altcoin portfolio on Bitvavo... I can't share it here, too many errors in the coins and you can still change it somehow. I then deleted the connection again.

I played soccer until I was 32 (including 3rd league, mostly 4th league for many years) and was able to save up some capital during this time, which I later invested.

My long-term core consists of:

$IWDA (+0,27%)

$EIMI (-0,11%)

$TDIV (+0,42%)

$BTC (-1,48%)

Dividend / cash flow portfolio

I also have a portfolio with a focus on cash flow, the aim is to hold around 15 stocks with a solid dividend yield and ideally dividend growth.

Currently included are:

$O (-0,94%) Realty Income

$RACE (-1,08%) Ferrari

$PEP (-2,21%) Pepsi

$MAIN (-0,39%) Main Street Capital

$NOVO B (+9,06%) Novo Nordisk

$ASML (+0,31%) ASML

$ITX (-0,2%) Inditex

$1211 (-1,05%) BYD

$ZTS (-0,46%) Zoetis

$BRO (-1,39%) Brown & Brown

$SBUX (-2,89%) Starbucks

$ITH (+3,25%) Ithaca Energy PLC

This brings my current total to 12 shares, so there is still room for one or two additions.

One of the stocks on my watchlist is Vonovia $VNA (+0,27%) with a dividend yield of just under 5%. However, the dividend growth doesn't look particularly good. As my wife will be starting work there soon, I've become more aware of the company for the first time ☺️

Other stocks on my watchlist:

Allianz

Vici

Linde

Microsoft

Waste Management

UnitedHealth Group

Mastercard

Visa

Texas Roadhouse

Nintendo

Enbridge

NextEra Energy

Wolters Kluwer (exciting sector, also corrected over 50% from ATH)

Amazon (for the yield/growth portfolio)

Maybe one or the other is missing $KO (-0,86%) or $MCD (-1,5%) but I had opted for $PEP (-2,21%) and $SBUX (-2,89%) and I don't want any more consumer stocks.

Pure growth portfolio

I also have a separate portfolio with a focus on share price growth:

$NVDA (+2,39%) Nvidia

$NKE (-0,39%) Nike

$MARA (-3,91%) Mara Holdings

$BITF (-1,51%) Bitfarms

$TTD (-0,92%) The Trade Desk

$CRCL (-6,24%) Circle Internet Group

$ADBE (-1,49%) Adobe

$COIN (-3,59%) Coinbase

$SMHN (-1,55%) Suess Microtec

$PYPL (-1,32%) PayPal

$HUT (+5,2%) Hat 8

$DRO (+2,76%) DroneShield

$LXS (-0,47%) Lanxess

$PLTR (-0,05%) Palantir

$WEED (-3,54%) Canopy

$UBI (-0,19%) Ubisoft

$MSTR (-4,27%) Strategy

I am aware that I have built up a lot of positions over the last two years. I am therefore also planning to sort out some of them and concentrate more on selected stocks.

I am grateful for any assessment, criticism, tips or suggestions.

Best regards

Chris